Hyperlactatemia is an independent predictor of mortality and denotes distinct subtypes of severe sepsis and septic shock

Journal of Critical Care

Volumn 30, Issue 2, 2015, Pages 439.e1-439.e6

  Thomas Rueddel, Daniel O ^a   Poidinger, Bernhard ^a   Weiss, Manfred ^b   Bach, Friedhelm ^c   Dey, Karin ^d   Häberle, Helene ^e   Kaisers, Udo ^f   Rüddel, Hendrik ^a   Schädler, Dirk ^g   Scheer, Christian ^h   Schreiber, Torsten ⁱ   Schürholz, Tobias ^j   Simon, Philipp ^f   Sommerer, Armin ^d   Schwarzkopf, Daniel ^a   Weyland, Andreas ^k   Wöbker, Gabriele ^l   Reinhart, Konrad ^a   Bloos, Frank ^a  

^a JENA UNIVERSITY HOSPITAL   (Germany)

^b UNIVERSITY HOSPITAL ULM   (Germany)

^c EVANGELISCHES KRANKENHAUS   (Germany)

^d Bundeswehrkrankenhaus Berlin   (Germany)

^e UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

^f UNIVERSITY HOSPITAL LEIPZIG   (Germany)

^g UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

^h UNIVERSITY OF GREIFSWALD   (Germany)

ⁱ ZENTRALKLINIK BAD BERKA   (Germany)

^j UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

^k KLINIKUM OLDENBURG   (Germany)

^l HELIOS KLINIKUM WUPPERTAL   (Germany)

more..

Author keywords

Critical care; Lactic acid; Sepsis; Septic shock

Indexed keywords

HYPERTENSIVE FACTOR; NORADRENALIN; LACTIC ACID; VASOCONSTRICTOR AGENT;

ADULT; AGED; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; HUMAN; HYPERLACTATEMIA; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MORTALITY; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; PHENOTYPE; PREDICTOR VARIABLE; PROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; SECONDARY ANALYSIS; SEPSIS; SEPTIC SHOCK; BLOOD; MIDDLE AGED; PROGNOSIS; RISK; SHOCK, SEPTIC; STATISTICAL MODEL; VERY ELDERLY;

AGED; AGED, 80 AND OVER; COHORT STUDIES; FEMALE; HUMANS; HYPERLACTATEMIA; LACTIC ACID; LOGISTIC MODELS; MALE; MIDDLE AGED; NOREPINEPHRINE; ODDS RATIO; PROGNOSIS; PROSPECTIVE STUDIES; SEPSIS; SHOCK, SEPTIC; VASOCONSTRICTOR AGENTS;

EID: 84923013132     PISSN: 08839441     EISSN: 15578615     Source Type: Journal    
DOI: 10.1016/j.jcrc.2014.10.027     Document Type: Article

References (34)

1. Abraham E., Singer M. Mechanisms of sepsis-induced organ dysfunction. Crit Care Med 2007, 35:2408-2416.
2. Bone R.C., Balk R.A., Cerra F.B., Dellinger R.P., Fein A.M., Knaus W.A., et al. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest 1992, 101:1644-1655.
3. Levy M.M., Fink M.P., Marshall J.C., Abraham E., Angus D., Cook D., et al. 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Crit Care Med 2003, 31:1250-1256.
4. Annane D., Vignon P., Renault A., Bollaert P.E., Charpentier C., Martin C., et al. Norepinephrine plus dobutamine versus epinephrine alone for management of septic shock: a randomised trial. Lancet 2007, 370:676-684.
5. Russell J.A., Walley K.R., Singer J., Gordon A.C., Hebert P.C., Cooper D.J., et al. Vasopressin versus norepinephrine infusion in patients with septic shock. N Engl J Med 2008, 358:877-887.
6. Sprung C.L., Annane D., Keh D., Moreno R., Singer M., Freivogel K., et al. Hydrocortisone therapy for patients with septic shock. N Engl J Med 2008, 358:111-124.
7. Ranieri V.M., Thompson B.T., Barie P.S., Dhainaut J.F., Douglas I.S., Finfer S., et al. Drotrecogin alfa (activated) in adults with septic shock. N Engl J Med 2012, 366:2055-2064.
8. Rivers E., Nguyen B., Havstad S., Ressler J., Muzzin A., Knoblich B., et al. Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med 2001, 345:1368-1377.
9. Annane D., Sebille V., Charpentier C., Bollaert P.E., Francois B., Korach J.M., et al. Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock. JAMA 2002, 288:862-871.
10. Hernandez G., Castro R., Romero C., de la Hoz C., Angulo D., Aranguiz I., et al. Persistent sepsis-induced hypotension without hyperlactatemia: is it really septic shock?. J Crit Care 2011, 26:435.e9-435.e14.
11. Otero R.M., Nguyen H.B., Huang D.T., Gaieski D.F., Goyal M., Gunnerson K.J., et al. Early goal-directed therapy in severe sepsis and septic shock revisited: concepts, controversies, and contemporary findings. Chest 2006, 130:1579-1595.
12. Puskarich M.A., Trzeciak S., Shapiro N.I., Heffner A.C., Kline J.A., Jones A.E. Outcomes of patients undergoing early sepsis resuscitation for cryptic shock compared with overt shock. Resuscitation 2011, 82:1289-1293.
13. Ranzani O.T., Monteiro M.B., Ferreira E.M., Santos S.R., Machado F.R., Noritomi D.T. Reclassifying the spectrum of septic patients using lactate: severe sepsis, cryptic shock, vasoplegic shock and dysoxic shock. Rev Bras Ter Intensiva 2013, 25:270-278.
14. Howell M.D., Donnino M., Clardy P., Talmor D., Shapiro N.I. Occult hypoperfusion and mortality in patients with suspected infection. Intensive Care Med 2007, 33:1892-1899.
15. Sterling S.A., Puskarich M.A., Shapiro N.I., Trzeciak S., Kline J.A., Summers R.L., et al. Characteristics and outcomes of patients with vasoplegic versus tissue dysoxic septic shock. Shock 2013, 40:11-14.
16. Marchick M.R., Kline J.A., Jones A.E. The significance of non-sustained hypotension in emergency department patients with sepsis. Intensive Care Med 2009, 35:1261-1264.
17. Trzeciak S., Dellinger R.P., Chansky M.E., Arnold R.C., Schorr C., Milcarek B., et al. Serum lactate as a predictor of mortality in patients with infection. Intensive Care Med 2007, 33:970-977.
18. Mikkelsen M.E., Miltiades A.N., Gaieski D.F., Goyal M., Fuchs B.D., Shah C.V., et al. Serum lactate is associated with mortality in severe sepsis independent of organ failure and shock. Crit Care Med 2009, 37:1670-1677.
19. Wacharasint P., Nakada T.A., Boyd J.H., Russell J.A., Walley K.R. Normal-range blood lactate concentration in septic shock is prognostic and predictive. Shock 2012, 38:4-10.
20. Hernandez G., Bruhn A., Castro R., Pedreros C., Rovegno M., Kattan E., et al. Persistent sepsis-induced hypotension without hyperlactatemia: a distinct clinical and physiological profile within the spectrum of septic shock. Crit Care Res Pract 2012, 2012:536852.
21. Bloos F., Thomas-Ruddel D., Ruddel H., Engel C., Schwarzkopf D., Marshall J.C., et al. Impact of compliance with infection management guidelines on outcome in patients with severe sepsis: a prospective observational multi-center study. Crit Care 2014, 18:R42.
22. Dellinger R.P., Levy M.M., Rhodes A., Annane D., Gerlach H., Opal S.M., et al. Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock, 2012. Intensive Care Med 2013, 39:165-228.
23. Cleveland W.S., Grosse E., Shyu W.M. Local regression models. Statistical Models in S 1992, 309-376. Chapman and Hall, New York. J.M. Chambers, T.J. Hastie (Eds.).
24. Donnino M.W., Nguyen B., Jacobsen G., Tomlanovich M., Rivers E. Cryptic septic shock: a sub-analysis of early, goal-directed therapy. Chest 2003, 124. [90s-90s].
25. De Backer D., Creteur J., Dubois M.J., Sakr Y., Koch M., Verdant C., et al. The effects of dobutamine on microcirculatory alterations in patients with septic shock are independent of its systemic effects. Crit Care Med 2006, 34:403-408.
26. Ait-Oufella H., Lemoinne S., Boelle P.Y., Galbois A., Baudel J.L., Lemant J., et al. Mottling score predicts survival in septic shock. Intensive Care Med 2011, 37:801-807.
27. Duke T. Dysoxia and lactate. Arch Dis Child 1999, 81:343-350.
28. Brealey D., Singer M. Mitochondrial dysfunction in sepsis. Curr Infect Dis Rep 2003, 5:365-371.
29. Ruggieri A.J., Levy R.J., Deutschman C.S. Mitochondrial dysfunction and resuscitation in sepsis. Crit Care Clin 2010, 26:567-575. [x-xi].
30. James J.H., Luchette F.A., McCarter F.D., Fischer J.E. Lactate is an unreliable indicator of tissue hypoxia in injury or sepsis. Lancet 1999, 354:505-508.
31. Donnino M.W, Carney E., Cocchi M.N., Barbash I., Chase M., Joyce N., et al. Thiamine deficiency in critically ill patients with sepsis. J Crit Care 2010, 25:576-581.
32. Levraut J., Ciebiera J.P., Chave S., Rabary O., Jambou P., Carles M., et al. Mild hyperlactatemia in stable septic patients is due to impaired lactate clearance rather than overproduction. Am J Respir Crit Care Med 1998, 157:1021-1026.
33. Hartemink K.J., Hack C.E., Groeneveld A.B. Relation between coagulation/fibrinolysis and lactate in the course of human septic shock. J Clin Pathol 2010, 63:1021-1026.
34. Andersen L.W., Mackenhauer J., Roberts J.C., Berg K.M., Cocchi M.N., Donnino M.W. Etiology and therapeutic approach to elevated lactate levels. Mayo Clin Proc 2013, 88:1127-1140.